“Potential pharmacological approach in the regulation of angiotensin-II conversion enzyme and dipeptidyl-peptidase 4 in diabetic COVID-19 patients” (2020) Italian Journal of Medicine, 15(1). doi:10.4081/itjm.2020.1435.